Agomab Therapeutics NV

AGMB · NASDAQ

$9.05−$0.21 (−2.27%)TodayMarket closed ·
Prev close $9.26

Who owns AGMB

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 50.3% of AGMB’s shares.

  • EQT Partners AB10.4%
  • Pontifax Venture Capital6.7%
  • Sanofi SA5.7%
  • Redmile Group, LLC5.6%
  • Next 6 largest institutions21.9%
  • All other shareholders49.7%
Top institutional holders of AGMB
HolderShares% of shares
EQT Partners AB5.14M10.44%
Pontifax Venture Capital3.31M6.71%
Sanofi SA2.78M5.65%
Redmile Group, LLC2.73M5.55%
Cormorant Asset Management, LP2.47M5.01%
TCG Crossover Management, LLC2.05M4.17%
Federated Hermes Global Investment Management Corp.1.62M3.29%
Nantahala Capital Management, LLC1.57M3.18%
Casdin Capital, LLC1.55M3.15%
Andera Partners S.A.S.1.54M3.12%

Largest mutual fund holders

Top mutual fund holders of AGMB
HolderShares% of shares
Federated Hermes Kaufmann Fund981.18K1.99%
Federated Hermes Kaufmann Small Cap Fund615.71K1.25%
Fidelity Growth Company Fund507.25K1.03%
abrdn Healthcare Investors Fund (US)290.87K0.59%
abrdn World Healthcare Fund275.00K0.56%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $399.97K (10 trades) of AGMB on the open market, with no sales.

Latest AGMB insider transactions
InsiderTypeSharesValue
Epstein David RBuy5.00K$44.50K
Epstein David RBuy5.00K$44.30K
Epstein David RBuy5.00K$44.50K
Knotnerus Tim JasperBuy5.00K$43.50K
Kemula Pierre Thadee VictorBuy2.00K$17.08K
Kemula Pierre Thadee VictorBuy5.00K$42.85K
Kemula Pierre Thadee VictorBuy3.00K$26.01K
Epstein David RBuy5.00K$43.50K
Knotnerus Tim JasperBuy6.00K$50.88K
Epstein David RBuy5.00K$42.85K

Short interest

Settled Sep 30, 2026

Shares short
1.00M
Days to cover
7.12
% of shares outstanding
2.03%
Average daily volume
140.68K
Change since last report
+15.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.